Automated Cell Culture System Market size was over USD 7.31 Billion in 2023 and is poised to cross USD 33.39 Billion by the end of 2036, growing at more than 12.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of automated cell culture system is estimated at USD 8.13 Billion. The growth of the market can primarily be attributed to the increasing stem cell research & development owing to the higher prevalence of related diseases. For instance, in 2019, more than 8 million people were found to be suffering from Parkinson’s disease.
A cell culture system is a process that consists particular instrument to conduct steps to grow and maintain cell culture. In a cell culture system, an environment is constituted to with controlled conditions, separated from the natural environment. Global automated cell culture market trends such as, escalating research and development activities and spiking prevalence of cancer are expected to influence the growth of the market over the forecast period. According to World Health Organization, cancer is designated as the leading cause of death, which caused about 10 million deaths in 2020, it is also stated by the similar source that in every 6 deaths, 1 is caused by cancer.
Growth Drivers
The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.
Challenges
|
Base Year |
2023 |
|
Forecast Period |
2024- 2036 |
|
CAGR |
12.4% |
|
Base Year Market Size (2023) |
USD 7.31 Billion |
|
Forecast Year Market Size (2036) |
USD 33.39 Billion |
End-user (Academic Institutes, Biotech Company)
The global automated cell culture system market is segmented and analyzed for demand and supply by end-user into academic institutes, biotech company, and research organization, out of which, the biotech company segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising activities of research and development across the globe. For instance, the biotech industry was valued at approximately USD 450 billion in 2020.
Mode of Delivery (Topical Application, Aerial Diffusion, Direct Inhalation)
On the other, on the basis of mode of delivery, automated cell culture system market is segmented into topical application, aerial diffusion, and direct inhalation. Out of all these, the topical application garnered the highest market share i.e. 41.03% in 2022. The rising technological advancements along with the huge investments made in the healthcare sector is expected to bring lucrative opportunities for the segment growth.
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Line Culture |
|
|
By Application |
|
|
By Mode of Delivery |
|
|
By End-User |
|
Regionally, the global automated cell culture system market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region holds the largest market share with 42.16% in 2022. The growth of the market is attributed to rising investment in research and development in the region. The National Cancer Institute (NIC) published statistics showing that the NCI budget to make funding for research for cancer reached USD 6440.4 million in 2020. Additionally, the higher prevalence of chronic diseases and the presence of major key players in the region is further expected to propel the growth of the market over the forecast period. Furthermore, the Europe region is also estimated to provide a lucrative opportunity for the market to grow exponentially.
Hitachi Power Solutions Co., Ltd. to launch FineSAT7, a scanning acoustic tomograph with higher image quality. this scanning acoustic tomograph is used to detect particular defects in the body with help of transmissive and reflective properties of ultrasonic waves.
Becton, Dickinson and Company to start the enrollment for the first-in-human trial for sirolimus drug-coated balloons (DCB). The company is conducting these trials to improve the treatment option for peripheral arterial diseases.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?